Acetylcysteine.
Research-backed compound with potential health benefits. Boosts glutathione, your body's main antioxidant. This helps protect your cells from damage. It's also an effective mucolytic, meaning it thins mucus to help clear your lungs.
Reviewed March 2026
- Category
- Compound
What Acetylcysteine is, and what it does.
- Does it work
- Yes, for specific goals. Great for respiratory health during a cold and for liver support. As a general antioxidant, the evidence is solid but the benefits are backstage.
- How much to take
- 600-1200mg per day, often split into two doses. Higher doses are used for mental health research, but this is the sweet spot for general support.
- Time to feel it
- Mucus feels looser within a day or two. The glutathione side moves slower and shows up on a blood marker across two to four weeks rather than as a sensation.
- The first dose
- If you have lung congestion, you might notice things loosening up. For anything else, you won't feel a thing. It's not a stimulant.
- With regular use
- Stronger antioxidant defenses. Better resilience against cellular stress. Some studies suggest benefits for mood and compulsive behaviors, but that's still being investigated.
- How well tolerated
- Generally well tolerated. The sulfur smell is off-putting but harmless. Taking it with food helps with potential stomach issues. Don't take it if you have active stomach ulcers.
- How it feels
- A silent worker. You don't feel it. Think of it as your body's cleanup crew working in the background, not a performance enhancer you notice immediately.
- The overlooked benefit
- Very little of the intact molecule survives the first pass through gut and liver. What rises in your blood is cysteine, and that is the part doing most of the work.
600 to 1,200mg a day is where Acetylcysteine works.
Source: Atkuri 2007 + Deepmala 2015 psych review
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Acetylcysteine is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- Glutathione statusRandomised trial
- Mucus viscosity and clearanceMeta-analysis
- Antioxidant defence markersRandomised trial
- Oxidative stress after hard exerciseRandomised trial
- Sperm quality markers in menRandomised trial
- Cysteine supply to the transsulfuration pathwayNarrative review
Questions people ask about Acetylcysteine.
- Why does it smell so bad?
- Sulfur. It's a key part of the molecule and what makes it work. The smell means it's legit. Hold your nose and swallow.
- Is it safe to take every day?
- Yes, for most people. Standard doses (600-1200mg) have a good safety record for long-term use.
- Will it help with a hangover?
- Theoretically, by supporting the liver. Take it before drinking, not after. A better plan is to drink less and hydrate more.
- Best time to take it?
- On an empty stomach is best for absorption. If it upsets your stomach, take it with food. Consistency matters more than timing.
- Is this the same stuff used in hospitals?
- Yes. High-dose IV NAC is the gold standard antidote for Tylenol (acetaminophen) poisoning. This actually works.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Cysteine is the rate-limiting substrate for glutathione synthesis, and N-acetylcysteine is a deacetylation step away from cysteine. Supplying it raises intracellular cysteine availability for glutamate-cysteine ligase, the first and controlling enzyme of the two-step synthesis. Oral glutathione itself is largely broken down to its constituent amino acids before absorption, so the two arrive at the same pool by different routes.
Glutathione is a tripeptide of glutamate, cysteine and glycine, so glycine is the third required substrate and can become limiting in older adults even when cysteine is plentiful. The combined glycine and N-acetylcysteine approach exists precisely because supplying one precursor without the other leaves synthesis constrained. This is stoichiometry rather than an interaction effect.
Glutamine is deamidated to glutamate, the third amino acid of the glutathione tripeptide and the partner cysteine is ligated to in the first synthesis step. In tissues with high glutamine turnover this supply route matters for how much glutathione can be assembled. The relationship is substrate provision, nothing more.
Glutathione peroxidases are selenoproteins that carry selenocysteine in the active site, and they are what actually spends glutathione to reduce peroxides. Raising glutathione without adequate selenium leaves the enzyme side of that pair under-supplied. The two sit on consecutive steps of the same defence.
Ascorbate and glutathione regenerate each other through the ascorbate-glutathione cycle, with glutathione reducing dehydroascorbate back to the active vitamin. Cysteine supplied as N-acetylcysteine therefore feeds a pool that ascorbate draws on. Both also keep thiol groups on other proteins in the reduced state.
Dihydrolipoate can reduce oxidised glutathione directly and can also spare cysteine by supporting its uptake into cells. The pairing therefore attacks the same pool from a synthesis and a regeneration angle at once. Both compounds carry free or reducible thiol chemistry, which is also why both smell and taste the way they do.
A free sulfhydryl group binds transition metals, and N-acetylcysteine is a documented chelator of copper. Regular high intake alongside copper could reduce how much of the mineral remains available. Spacing the two is the usual practical response, and this cuts both ways for anyone deliberately supplementing copper.
Thiol groups coordinate zinc, which is the basis of every zinc finger in the genome, so a free-thiol compound in the gut lumen can bind dietary zinc. The practical size of this effect at supplement doses has not been quantified. Taking the two at separate times avoids the question entirely.
Activated charcoal adsorbs small organic molecules non-selectively in the gut lumen, and N-acetylcysteine is exactly the kind of compound it binds. Taken together, less of the thiol is available for absorption. This is a general rule for charcoal and any oral active, not a special property of this pairing.
N-acetylcysteine is L-cysteine with an acetyl group on the amino nitrogen, added because free cysteine oxidises readily to cystine and is unstable in a capsule. Intestinal and hepatic deacetylases remove that group after absorption. The acetyl is a stability device, not a separate active feature.
Methionine feeds cysteine synthesis through the transsulfuration pathway by way of homocysteine and cystathionine, which is the body's own route to the amino acid. Supplying cysteine directly reduces the draw on that pathway. The two therefore converge on the same pool from opposite directions.
Both enzymes of transsulfuration, cystathionine beta-synthase and cystathionine gamma-lyase, require pyridoxal 5-phosphate as cofactor. Without adequate B6 the body's own conversion of homocysteine to cysteine slows. That makes B6 status part of the picture for anyone thinking about cysteine supply.
Betaine remethylates homocysteine back to methionine, pulling flux away from the transsulfuration branch that produces cysteine. N-acetylcysteine acts on the other side of that junction by supplying cysteine directly. The two therefore both touch homocysteine handling, from different arms.
S-adenosylmethionine is the allosteric activator of cystathionine beta-synthase, the committing step that routes homocysteine toward cysteine. Its concentration is one of the switches that decides whether one-carbon flux goes to remethylation or to thiol synthesis. N-acetylcysteine bypasses that regulation entirely.
Taurine is made from cysteine through cysteine dioxygenase and decarboxylation, so cysteine availability sits upstream of taurine synthesis. Supplying N-acetylcysteine feeds a pool that branches to both glutathione and taurine. Which branch dominates depends on cysteine dioxygenase activity, which is itself regulated by cysteine levels.
Sulfite oxidase, a molybdenum-dependent enzyme, handles the sulfite generated as cysteine is catabolised. Higher sulfur amino acid intake raises the load on that step. Molybdenum status is therefore part of normal sulfur handling rather than a partner with any independent action here.
Myo-inositol and N-acetylcysteine are routinely combined in formulas aimed at normal ovulatory cycles and insulin signalling, where each is studied separately for those measures. Inositol works as a second messenger precursor while N-acetylcysteine works through thiol redox chemistry, so the mechanisms do not overlap. The pairing rests on convention and on separate single-ingredient trials, not on a head-to-head combination study cited here.
One report examined vitamin D and N-acetylcysteine supplementation together against mood, cognition and blood biomarkers. It reports associations, which are not causal findings, and the two ingredients were assessed as a pair. Their mechanisms, nuclear receptor signalling and thiol supply, are unrelated.
Silymarin supports hepatocyte glutathione content and membrane integrity, while N-acetylcysteine supplies the limiting amino acid for glutathione synthesis. They arrive at liver antioxidant capacity by different routes and are commonly formulated together for that reason. No trial of the specific combination is cited here.
NAC and acetylcysteine name the same molecule, N-acetyl-L-cysteine, under a common abbreviation and its full chemical name. Anything true of one is true of the other. This row exists so the two catalogue entries are not read as separate ingredients that could be stacked.
Nothing specific on file for Acetylcysteine. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Acetylcysteine actually does.
N-acetylcysteine is L-cysteine bearing an acetyl group on the alpha-amino nitrogen, which stops the amino acid oxidising to cystine during manufacture and storage.
After absorption, cellular and hepatic deacetylases remove the acetyl group to release free L-cysteine, and most of the compound's activity is the activity of that cysteine.
Cysteine is the rate-limiting substrate for glutathione, the tripeptide the body uses in the largest quantity for intracellular thiol defence, so cysteine supply directly gates how much glutathione a cell can build.
The free sulfhydryl group reduces disulfide bonds, which is the chemistry behind its long-standing use to lower the viscosity of mucus glycoprotein networks.
Where Acetylcysteine comes from.
It starts as the amino acid cysteine, which is either grown by bacteria in a fermentation tank or pulled out of keratin such as feathers. A small acetyl group is then attached to make it stable in a capsule, and the powder is purified and dried.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
L-cysteine reaches the market by two distinct routes: microbial fermentation using engineered Escherichia coli or Corynebacterium on a sugar and sulfur source, and acid hydrolysis of keratin from duck feathers or human hair, which is still used in some regions. Vegan and kosher or halal certifications turn on which route was used.
The alpha-amino group of L-cysteine is acetylated, usually with acetic anhydride under controlled pH and temperature, protecting the thiol from oxidation during the reaction.
The product is crystallised from aqueous or alcoholic solution and washed to remove acetic acid residues, unreacted cysteine and the oxidised cystine by-product.
Material is assayed by titration or chromatography for purity and residual solvents, and checked to confirm the L-configuration was retained.
The dried crystals are encapsulated, compressed, blended into an effervescent base, or packed as bulk powder in a moisture-barrier container.
Many labels do not state which cysteine route was used, which is the detail that decides whether the material is plant-suitable.
Getting Acetylcysteine from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Across trials in adult men, N-acetylcysteine supplementation was associated with better antioxidant and muscle-damage blood markers after exercise, while measured physical performance itself varied between studies.Systematic review. Fernández-Lázaro et al., 2023 (Nutrients). PMID 37299425 ↗
- Pooling trials in men with low sperm quality measures, N-acetylcysteine supplementation was associated with higher sperm concentration, motility and proportion of normally shaped sperm than control.Meta-analysis. Syarif et al., 2025 (Archivio Italiano di Urologia e Andrologia). PMID 40126496 ↗
- A systematic review pooled trials of N-acetylcysteine given around an endoscopic bile-duct procedure and examined rates of a procedural complication; the review notes variation in dose and route across studies.Systematic review. Hormati et al., 2025 (BMC Gastroenterology). PMID 41188701 ↗
- Pooled trials in women with irregular ovulation and raised androgen markers report changes in metabolic and hormonal measures with N-acetylcysteine; most included studies are small.Meta-analysis. Vina et al., 2025 (Nutrients). PMID 39861414 ↗
- The authors report that N-acetylcysteine supplementation improved endocrine and metabolic blood profiles and ovulation induction measures in the pooled trials; blood profiles are markers, ovulation rate is an outcome.Meta-analysis. Fang et al., 2024 (Journal of Ovarian Research). PMID 39415242 ↗
- Prophylactic N-acetylcysteine was assessed against postoperative measures in elective double-valve heart surgery, a controlled hospital setting that does not generalise to everyday supplement use.Randomised trial. Ram Kiran et al., 2024 (Annals of Cardiac Anaesthesia). PMID 39365130 ↗
- N-acetylcysteine supplementation shifted several oxidative-stress and inflammatory blood markers alongside activity scores; the markers are laboratory measures rather than outcomes.Randomised trial. Esalatmanesh et al., 2022 (Amino Acids). PMID 35133468 ↗
- Oral N-acetylcysteine was associated with changes in immune cell and cytokine measures in a hospital cardiac care setting; these are immunological markers, not clinical endpoints.Randomised trial. Wasyanto et al., 2019 (Acta Medica Indonesiana). PMID 32041914 ↗
- Intravenous N-acetylcysteine was given to critically ill adults during the 2020 to 2021 hospital period and biochemical responses were tracked; the route was intravenous and does not describe oral supplement use.Randomised trial. Gamarra-Morales et al., 2023 (Nutrients). PMID 37405379 ↗
- A systematic review gathers trials of N-acetylcysteine in adults receiving care for substance use and trauma-related mental health conditions, and describes the evidence base as heterogeneous.Systematic review. Ahmed et al., 2026 (BMC Psychiatry). PMID 42115982 ↗
- A prospective randomised study gave antenatal N-acetylcysteine in a hospital obstetric setting and reported measures in mothers and newborns; this is a supervised clinical protocol, not general supplement use in pregnancy.Randomised trial. Kuster et al., 2026 (Pediatric Research). PMID 42177307 ↗
- As a feed additive in poultry, N-acetylcysteine reduced markers of ochratoxin A toxicity; a poultry feeding study does not transfer to human dosing.Animal study. Tanveer et al., 2025 (Food Additives and Contaminants Part A). PMID 40803992 ↗
These are the studies our verdict leans on, chosen from the 9,463 we read for Acetylcysteine. The full linked list is below.
The studies, linked.
11 sources behind our Acetylcysteine verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialCardiac Arrhythmia Catheter Ablation Procedures Guided by x-Ray Imaging: N-Acetylcysteine Protection Against Radiation Induced Cellular damagE (CARAPACE Study)ClinicalTrials.gov ↗PHASE2 · 181 participants · Completed
- Clinical trialN-Acetylcysteine Versus L-carnitine in Clomiphene Citrate Resistant Pcos Women. a Randomized Controlled TrialClinicalTrials.gov ↗PHASE2 · 164 participants · Completed
- Clinical trialA Prospective Randomized Controlled Trial of Adjunctive N-acetylcysteine (NAC) in Adult Patients With Pulmonary Tuberculosis: a Sub-study of TB SequelClinicalTrials.gov ↗PHASE2 · 110 participants · Completed
- Clinical trialEffectiveness of N-Acetylcysteine in Motivational Enhancement Therapy for Nicotine Addiction: Study on the Dopaminergic Pathways, Changes in Functional Connectivity of fMRI Bold, and Changes in Smoking AbstinenceClinicalTrials.gov ↗PHASE4 · 90 participants · Completed
- Clinical trialPilot Study: Postoperative Pain Reduction by Pre Emptive N-AcetylcysteineClinicalTrials.gov ↗PHASE4 · 60 participants · Completed
- Clinical trialA Randomized, Placebo-Controlled Pilot Trial Assessing Two Doses of N-Acetylcysteine on Changes in Oxidative Stress and Endothelial Function in HIV-infected Older Adults Receiving Stable Antiretroviral TherapyClinicalTrials.gov ↗PHASE1 · 24 participants · Completed
- Clinical trialSupplementation of N-acetylcysteine and Arachonic Acid in Type 1 Diabetes to Determine Changes in Oxidative StressClinicalTrials.gov ↗EARLY PHASE1 · 8 participants · Terminated
- Clinical trialTreatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine (NAC) (SNAC)ClinicalTrials.gov ↗PHASE2 · 290 participants · Active not recruiting
- Clinical trialEfficacy of N-Acetylcysteine in Improving/Normalizing ALT & AST in Patients of NAFLDClinicalTrials.gov ↗NA · 100 participants · Unknown
- Clinical trialA Randomized Prospective Trial of N-acetyl Cystein in Patients With Peritoneal DialysisClinicalTrials.gov ↗PHASE4 · 66 participants · Unknown
- Clinical trialEffect of N-Acetylcysteine on Peritoneal Membrane Function in Chronic Peritoneal Dialysis Patients.ClinicalTrials.gov ↗NA · 20 participants · Unknown
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 108,992 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Acetylcysteine is, not how risky it is. A report is not proof Acetylcysteine caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.